RedHawk Holdings Corp. Stocks

$ 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 131690

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

RedHawk Holdings Corp., through its subsidiaries, engages in sale and distribution of medical devices, and sale of branded generic pharmaceutical drugs primarily in the United States and the United Kingdom. It operates in three segments: Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. The company manufactures and sells Sharps and Needle Destruction Devices; carotid artery digital non-contact thermometers; and Centri Controlled Entry System, a full body X-ray scanner. It also distributes WoundClot, a bleeding control medical device; Berrcom JXB178 infrared non-contact thermometers; and Zonis. In addition, RedHawk Holdings Corp. sells a line of face masks and face shields, including a level 1 single use disposable mask, a three layer level 3 cotton masks, and KN95 and N95 masks; an anti-fog and anti-static splash protection face shield; and a line of ultraviolet sanitation lights, including tabletop and handheld devices, as well as branded generic pharmaceuticals, such as Paracetamol, Glipizide, and Omeprazole. The company serves retail pharmacies, hospitals, physicians' offices, private and public healthcare clinics, corrections facilities, schools, veterinary clinics, emergency services, first responders, municipalities, and long term care facilities. In addition, it is involved in the commercial and residential property investment and leasing activities; sale of point of entry full-body security systems; and provision of specialized financial services. The company was formerly known as Independence Energy Corp. and changed its name to RedHawk Holdings Corp. in October 2015. RedHawk Holdings Corp. was incorporated in 2005 and is headquartered in Lafayette, Louisiana.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks